Firefly Neuroscience (AIFF)
NASDAQ:AIFF
Want to see AIFF full AI Analyst Report?
AIFF Stock Chart & Stats
$1.05
-$0.10(-4.05%)
At close: 4:00 PM EST
$1.05
-$0.10(-4.05%)
Day’s Range― - ―
52-Week Range$0.62 - $3.77
Previous CloseN/A
Volume11.65K
Average Volume (3M)316.76K
Market Cap
$27.56M
Enterprise Value$24.44M
Total Cash (Recent Filing)$3.13M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.30
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.68
Shares Outstanding15,571,780
10 Day Avg. Volume358,037
30 Day Avg. Volume316,761
Financial Highlights & Ratios
PEG Ratio-0.04
Price to Book (P/B)1.51
Price to Sales (P/S)10.11
P/FCF Ratio-1.39
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue15.43
Enterprise Value/Gross Profit29.69
Enterprise Value/Ebitda-2.80
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Strong Revenue Growth And Solid Gross MarginSustained TTM revenue growth of ~38.7% combined with ~52% gross margin indicates the company is generating scalable top-line momentum with underlying unit economics. These fundamentals support long-term margin improvement as fixed costs are spread over larger revenue and validate product-market fit in research/clinical markets.
Debt-free Balance Sheet With Positive EquityHaving no debt and positive stockholders' equity reduces solvency and interest-rate risk, giving management flexibility to fund growth via equity or strategic partnerships. This structural strength lowers mandatory cash outflows and preserves operating cash for R&D and commercialization initiatives over the medium term.
Business Aligned With Durable Neurotech/AI TrendFirefly's focus on AI-driven EEG analytics targets structural demand for objective digital biomarkers in neurology and psychiatry. That secular trend—larger clinical research spend and increased interest in quantitative diagnostics—supports persistent market opportunities and long-term commercial adoption of its platform.
Bears Say
High Cash Burn And Negative Operating Cash FlowMaterial negative operating and free cash flow demonstrate the company is burning cash to fund operations rather than self-funding growth. This persistent cash burn creates ongoing reliance on external financing, raises dilution risk, and constrains the firm's ability to invest opportunistically without new capital.
Severely Negative Profitability MetricsA deeply negative net margin and continued large operating losses indicate the cost base far exceeds current revenue. Until revenues scale substantially or costs are restructured, profitability is unlikely, which undermines long-term return on capital and increases the probability of further dilution or strategy shifts.
Dependence On Equity Financings With Closing RisksRecent private placements and a financing facility relieve near-term cash needs but tie capital access to shareholder approvals, SEC filings and market conditions. That dependence creates execution risk, potential dilution from warrants/issuances, and uncertainty about sustainable funding sources beyond short-term financings.
Firefly Neuroscience News
AIFF FAQ
What was Firefly Neuroscience’s price range in the past 12 months?
Firefly Neuroscience lowest stock price was $0.62 and its highest was $3.77 in the past 12 months.
What is Firefly Neuroscience’s market cap?
Firefly Neuroscience’s market cap is $27.56M.
When is Firefly Neuroscience’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Firefly Neuroscience’s earnings last quarter?
Firefly Neuroscience released its earnings results on May 14, 2024. The company reported -$0.335 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.335.
Is Firefly Neuroscience overvalued?
According to Wall Street analysts Firefly Neuroscience’s price is currently Overvalued.
Does Firefly Neuroscience pay dividends?
Firefly Neuroscience does not currently pay dividends.
What is Firefly Neuroscience’s EPS estimate?
Firefly Neuroscience’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Firefly Neuroscience have?
Firefly Neuroscience has 15,571,780 shares outstanding.
What happened to Firefly Neuroscience’s price movement after its last earnings report?
Firefly Neuroscience reported an EPS of -$0.335 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.455%.
Which hedge fund is a major shareholder of Firefly Neuroscience?
Currently, no hedge funds are holding shares in AIFF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Technical Analysis
Ownership Overview
11.85% Insiders
1.30% Mutual Funds
0.47% Other Institutional Investors
85.46% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---